(2) The second meeting was held at Kuala Lumpur in 2008, hosted a

(2) The second meeting was held at Kuala Lumpur in 2008, hosted at

the 11th Asian Pacific Congress of Nephrology (APCN) by Zaki Morad, President of the 11th APCN. (3) The International Organising Committee (IOC) of the AFCKDI will continue its function by adding other experts, including the organiser of the next meeting. (4) The AFCKDI is not an organisation by itself nor does it belong to any society. Meetings will be organised by each host national society of nephrology. The IOC will assist the domestic committee for the success of the forum and will assure the continuation of the mission. (5) In order to organise the forum and promote CKD initiatives in the Asian Pacific ALK inhibitor drugs region, the AFCKDI will look for support by both national and international societies. The AFCKDI will keep an intimate and GW-572016 datasheet mutual relation with the ISN, APSN and KDIGO. Finally, we have reached the following consensus as the mission of the AFCKDI and decided on the continuation of this effort in the future: (1) to develop a consensus as a protocol of CKD detection in our region; (2) to analyse risk factors and cost-effective evaluation of the intervention; (3) to establish a network on the CKD Initiative in our region; (4)

to contribute AR-13324 in vivo to the global initiative by using resources in our region. Acknowledgments The AFCKDI 2007 was organised by the JSN and also supported by funds from the APSN, ISN-CME and the Australian New Zealand Society of Nephrology. The authors express sincere thanks to every participant in this forum for their enthusiasm and passionate discussion. Every abstract and the list of participants are available on the website http://​www.​jsn.​or.​jp/​AFCKDI2007/​index.​html. Appendix Organization President: Akira Hishida (President, JSN). Secretary General: Yusuke Tsukamoto, Secretary: Yoshinari Yasuda. International Organizing Committee. Haiyan Wang (Co-chair), Yusuke Tsukamoto (Co-chair), Gavin Becker, Evan Lee Jon Choon, Hung-Chun Chen, Dae-Suk Han, Vivekanand Jha, Philip

KT Li, Kriang Tungsanga, and Rowan Walker. Domestic Organizing Committee: Seiichi Matsuo (Chair), Kunitoshi Iseki (Co-chair), 3-oxoacyl-(acyl-carrier-protein) reductase Tadao Akizawa, Yasuhiro Ando, Masafumi Fukagawa, Yasuhiko IIno, Takashi Igarashi, Hiroyasu Iso, Iekuni Ichikawa, Sadayoshi Ito, Yuhei Ito, Daijo Inaguma, Enyu Imai, Hirokazu Imai, Shunya Uchida, Nobuyuki Ura, Masayuki Endo, Kazo Kaizu, Naoki Kashihara, Yutaka Kiyohara, Yasuhiko Tomino, Ichiei Narita, Kosaku Nitta, Masakazu Haneda, Shigeko Hara, Hideki Hirakata, Masaru Horio, Hirofumi Makino, Takeshi Matsuyama, Toshio Miyata, Toshiki Moriyama, Kunihiro Yamagata, Kenji Wakai, Tsuyoshi Watanabe. Hosted by the Japanese Society of Nephrology. Affiliated by the Asian Pacific Society of Nephrology, the International Society of Nephrology-COMGAN, the KDIGO/Kidney Disease: Improving Global Outcomes. References 1. Imai E, Yamagata K, Iseki K, Iso H, Horio M, Makino H, et al. Kidney disease screening program in Japan: history, outcome, and perspectives.

Comments are closed.